About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2018
2017
2016
2015
2014
16
Dec
2016
16:30 E.S.T.
Cellectis Announces Conference Call To Discuss Recent Recombinant DNA Advisory Committee (RAC) Meeting
Read more
15
Dec
2016
16:30 E.S.T.
Cellectis Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of UCART123 Phase 1 Study Protocols in AML and BPDCN
Read more
22
Nov
2016
16:30 E.S.T.
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016
Read more
21
Nov
2016
16:30 E.S.T.
Cellectis to Participate in Oppenheimer Life Sciences Summit, NY & in Piper Jaffray 28th Annual Health Care Conference, NY
Read more
15
Nov
2016
16:30 E.S.T.
Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate: UCART123
Read more
31
Oct
2016
16:30 E.S.T.
Cellectis Hosts World’s First Gene Edited Dinner in NYC
Read more
04
Oct
2016
16:30 E.S.T.
Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued in December 2014
Read more
28
Sep
2016
16:30 E.S.T.
Cellectis Wins 2016 Most Innovative European Biotech SME Award for Healthcare
Read more
09
Sep
2016
16:30 E.S.T.
Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results
Read more
27
Jun
2016
16:30 E.S.T.
MIT Technology Review Names Cellectis on Annual List of 50 Smartest Companies for Second Consecutive Year
Read more
1
2
3
Next